Skip to main content
Premium Trial:

Request an Annual Quote

Germany's Synlab to Use Bruker Mass Spec Tech for Microbial Identification

NEW YORK (GenomeWeb News) – Bruker Daltonics and German diagnostic lab association Synlab have forged an agreement in the area of molecular microbial identification based on MALDI-TOF mass spectrometry, Bruker said today.

Under the agreement, Synlab will equip its laboratories exclusively with Bruker's MALDI Biotyper system for molecular microbial identification.

In addition, Bruker and Synlab intend to further enlarge and refine the MALDI Biotyper reference library using well-defined clinical isolates from Synlab's routine microbiology work.

Synlab, a European private diagnostic laboratory association, has more than 70 diagnostic laboratories in Germany and other European countries. Synlab’s clinical microbiology centers in Trier, Weiden, and Dachau, Germany, already routinely use the MALDI Biotyper, Bruker said.

"After evaluating the MALDI Biotyper very thoroughly within the Synlab group, we are convinced that Bruker Daltonics is the most reliable partner for microbial identification based on mass spectrometry, and is providing outstanding microbiological service and support," Ulrich Knipp, technical head of microbiology at Synlab in Trier, said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.